These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 17124252

  • 1. Microchimeric cells: guardians or actors of immunity in scleroderma?
    Lambert NC.
    Rheumatology (Oxford); 2007 Mar; 46(3):382-3. PubMed ID: 17124252
    [No Abstract] [Full Text] [Related]

  • 2. Immunophenotyping of chimeric cells in localized scleroderma.
    McNallan KT, Aponte C, el-Azhary R, Mason T, Nelson AM, Paat JJ, Crowson CS, Reed AM.
    Rheumatology (Oxford); 2007 Mar; 46(3):398-402. PubMed ID: 17085771
    [Abstract] [Full Text] [Related]

  • 3. Pregnancy immunology and autoimmune disease.
    Nelson JL.
    J Reprod Med; 1998 Apr; 43(4):335-40. PubMed ID: 9583065
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Microchimerism in Japanese patients with systemic sclerosis.
    Ichikawa N, Kotake S, Hakoda M, Kamatani N.
    Arthritis Rheum; 2001 May; 44(5):1226-8. PubMed ID: 11352259
    [No Abstract] [Full Text] [Related]

  • 10. Microchimerism and systemic sclerosis.
    Jimenez SA, Artlett CM.
    Curr Opin Rheumatol; 2005 Jan; 17(1):86-90. PubMed ID: 15604910
    [Abstract] [Full Text] [Related]

  • 11. The vascular, inflammatory, and fibrotic components in scleroderma skin.
    Fleischmajer R, Perlish JS.
    Monogr Pathol; 1983 Jan; 24():40-54. PubMed ID: 6350857
    [No Abstract] [Full Text] [Related]

  • 12. Pathophysiology of fetal microchimeric cells.
    Artlett CM.
    Clin Chim Acta; 2005 Oct; 360(1-2):1-8. PubMed ID: 15979602
    [Abstract] [Full Text] [Related]

  • 13. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J, Farge D, Braccini A, Lecourt S, Scherberich A, Foïs E, Verrecchia F, Daikeler T, Gluckman E, Tyndall A, Bocelli-Tyndall C.
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [Abstract] [Full Text] [Related]

  • 14. [Progressive systemic sclerosis. A diagnostic problem].
    Posada de la Paz M, Martínez L de Letona J, Masa Vázquez C, Ruiz Galiana J, Pérez Alvarez R, Díez García F, Pérez Maestu R.
    Rev Clin Esp; 1983 Sep 30; 170(6):237-41. PubMed ID: 6361922
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Immunohistochemical findings in a case of scleroderma. Autoimmune sclerogenic microangiopathy].
    Nicòtina PA, Giarrizzo S, Scuderi C, Grosso M, Carrozza G.
    Pathologica; 1982 Sep 30; 74(1032):525-32. PubMed ID: 6761635
    [No Abstract] [Full Text] [Related]

  • 17. Stimulatory autoantibodies to the PDGF receptor in scleroderma.
    Okamoto H.
    N Engl J Med; 2006 Sep 21; 355(12):1278; author reply 1279. PubMed ID: 16998964
    [No Abstract] [Full Text] [Related]

  • 18. [Is scleroderma an allo-immune disease?].
    Cosnes A, Cabane J, Humbert P, Emmerich J, Bagot M, Maquart FX, Aractingi S.
    Ann Dermatol Venereol; 1999 Mar 21; 126(3):291-4. PubMed ID: 10394448
    [No Abstract] [Full Text] [Related]

  • 19. Quantification and molecular characterization of regulatory T cells in connective tissue diseases.
    Banica L, Besliu A, Pistol G, Stavaru C, Ionescu R, Forsea AM, Tanaseanu C, Dumitrache S, Otelea D, Tamsulea I, Tanaseanu S, Chitonu C, Paraschiv S, Balteanu M, Stefanescu M, Matache C.
    Autoimmunity; 2009 Jan 21; 42(1):41-9. PubMed ID: 18800250
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.